ExodusPoint Capital Management’s Arcturus Therapeutics ARCT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-56,054	Closed	-$729K	–	1515
2025 Q2	$729K	Buy	56,054 +1,140	+2%	+$13.5K	0.01%	1051
2025 Q1	$582K	Buy	+54,914	New	+$872K	0.01%	1079
2024 Q1	–	Sell	-9,499	Closed	-$300K	–	1474
2023 Q4	$300K	Sell	9,499 -13,538	-59%	-$322K	﹤0.01%	1183
2023 Q3	$589K	Buy	23,037 +1,861	+9%	+$57.3K	0.01%	1180
2023 Q2	$607K	Sell	21,176 -8,988	-30%	-$245K	﹤0.01%	1286
2023 Q1	$723K	Buy	30,164 +348	+1%	+$6.24K	0.01%	1244
2022 Q4	$506K	Sell	29,816 -17,736	-37%	-$309K	0.01%	1170
2022 Q3	$705K	Buy	+47,552	New	+$798K	0.01%	1244
2021 Q4	–	Sell	-21,937	Closed	-$1.05M	–	2144
2021 Q3	$1.05M	Buy	+21,937	New	+$983K	0.01%	1000
2021 Q1	–	Sell	-23,302	Closed	-$1.01M	–	2098
2020 Q4	$1.01M	Sell	23,302 -13,753	-37%	-$931K	0.01%	853
2020 Q3	$1.59M	Buy	+37,055	New	+$1.84M	0.03%	479
2020 Q1	–	Sell	-11,135	Closed	-$121K	–	1068
2019 Q4	$121K	Buy	+11,135	New	+$117K	﹤0.01%	1411